Logo image of JBSS

JOHN B. SANFILIPPO & SON INC (JBSS) Stock Fundamental Analysis

NASDAQ:JBSS - Nasdaq - US8004221078 - Common Stock - Currency: USD

66.03  -0.71 (-1.06%)

Fundamental Rating

5

Overall JBSS gets a fundamental rating of 5 out of 10. We evaluated JBSS against 91 industry peers in the Food Products industry. JBSS has an excellent profitability rating, but there are some minor concerns on its financial health. JBSS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

JBSS had positive earnings in the past year.
JBSS had a positive operating cash flow in the past year.
JBSS had positive earnings in each of the past 5 years.
Each year in the past 5 years JBSS had a positive operating cash flow.
JBSS Yearly Net Income VS EBIT VS OCF VS FCFJBSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

With an excellent Return On Assets value of 9.39%, JBSS belongs to the best of the industry, outperforming 91.21% of the companies in the same industry.
Looking at the Return On Equity, with a value of 15.99%, JBSS belongs to the top of the industry, outperforming 83.52% of the companies in the same industry.
JBSS has a better Return On Invested Capital (11.65%) than 87.91% of its industry peers.
JBSS had an Average Return On Invested Capital over the past 3 years of 17.40%. This is significantly below the industry average of 28.19%.
The 3 year average ROIC (17.40%) for JBSS is well above the current ROIC(11.65%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 9.39%
ROE 15.99%
ROIC 11.66%
ROA(3y)13.43%
ROA(5y)13.71%
ROE(3y)20.79%
ROE(5y)21.94%
ROIC(3y)17.4%
ROIC(5y)18.17%
JBSS Yearly ROA, ROE, ROICJBSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 5.00%, JBSS is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
JBSS's Profit Margin has improved in the last couple of years.
The Operating Margin of JBSS (7.15%) is better than 68.13% of its industry peers.
JBSS's Operating Margin has improved in the last couple of years.
The Gross Margin of JBSS (18.48%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of JBSS has grown nicely.
Industry RankSector Rank
OM 7.15%
PM (TTM) 5%
GM 18.48%
OM growth 3Y-7.81%
OM growth 5Y3.1%
PM growth 3Y-6.7%
PM growth 5Y4.61%
GM growth 3Y-2.34%
GM growth 5Y2.13%
JBSS Yearly Profit, Operating, Gross MarginsJBSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so JBSS is creating value.
Compared to 1 year ago, JBSS has about the same amount of shares outstanding.
Compared to 5 years ago, JBSS has more shares outstanding
The debt/assets ratio for JBSS is higher compared to a year ago.
JBSS Yearly Shares OutstandingJBSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
JBSS Yearly Total Debt VS Total AssetsJBSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 5.11 indicates that JBSS is not in any danger for bankruptcy at the moment.
JBSS has a better Altman-Z score (5.11) than 87.91% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that JBSS is not too dependend on debt financing.
JBSS has a Debt to Equity ratio of 0.28. This is in the better half of the industry: JBSS outperforms 67.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 5.11
ROIC/WACC1.28
WACC9.08%
JBSS Yearly LT Debt VS Equity VS FCFJBSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.01 indicates that JBSS has no problem at all paying its short term obligations.
JBSS has a Current ratio of 2.01. This is in the better half of the industry: JBSS outperforms 67.03% of its industry peers.
JBSS has a Quick Ratio of 2.01. This is a bad value and indicates that JBSS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.53, JBSS is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.53
JBSS Yearly Current Assets VS Current LiabilitesJBSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for JBSS have decreased strongly by -14.75% in the last year.
The Earnings Per Share has been growing by 8.51% on average over the past years. This is quite good.
The Revenue has been growing slightly by 7.40% in the past year.
The Revenue has been growing slightly by 4.01% on average over the past years.
EPS 1Y (TTM)-14.75%
EPS 3Y-0.06%
EPS 5Y8.51%
EPS Q2Q%49.57%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y7.51%
Revenue growth 5Y4.01%
Sales Q2Q%-4.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBSS Yearly Revenue VS EstimatesJBSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
JBSS Yearly EPS VS EstimatesJBSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

JBSS is valuated correctly with a Price/Earnings ratio of 13.93.
JBSS's Price/Earnings ratio is a bit cheaper when compared to the industry. JBSS is cheaper than 70.33% of the companies in the same industry.
JBSS is valuated cheaply when we compare the Price/Earnings ratio to 27.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.93
Fwd PE N/A
JBSS Price Earnings VS Forward Price EarningsJBSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBSS indicates a somewhat cheap valuation: JBSS is cheaper than 75.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.48
JBSS Per share dataJBSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

JBSS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.64
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

JBSS has a Yearly Dividend Yield of 1.31%.
JBSS's Dividend Yield is comparable with the industry average which is at 4.67.
Compared to an average S&P500 Dividend Yield of 2.32, JBSS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

The dividend of JBSS has a limited annual growth rate of 3.19%.
JBSS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)3.19%
Div Incr Years0
Div Non Decr Years0
JBSS Yearly Dividends per shareJBSS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

65.00% of the earnings are spent on dividend by JBSS. This is not a sustainable payout ratio.
JBSS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65%
EPS Next 2YN/A
EPS Next 3YN/A
JBSS Yearly Income VS Free CF VS DividendJBSS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
JBSS Dividend Payout.JBSS Dividend Payout, showing the Payout Ratio.JBSS Dividend Payout.PayoutRetained Earnings

More info and screens

JOHN B. SANFILIPPO & SON INC

NASDAQ:JBSS (7/30/2025, 2:57:24 PM)

66.03

-0.71 (-1.06%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)08-20 2025-08-20
Inst Owners92.71%
Inst Owner Change-0.14%
Ins Owners0.96%
Ins Owner Change-26.21%
Market Cap776.51M
Analysts85.71
Price TargetN/A
Short Float %2.59%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend3
Dividend Growth(5Y)3.19%
DP65%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-19 2025-08-19 (0.6)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.93
Fwd PE N/A
P/S 0.7
P/FCF N/A
P/OCF 26.55
P/B 2.24
P/tB 2.35
EV/EBITDA 7.48
EPS(TTM)4.74
EY7.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.6
FCFYN/A
OCF(TTM)2.49
OCFY3.77%
SpS94.2
BVpS29.47
TBVpS28.07
PEG (NY)N/A
PEG (5Y)1.64
Profitability
Industry RankSector Rank
ROA 9.39%
ROE 15.99%
ROCE 19.05%
ROIC 11.66%
ROICexc 11.68%
ROICexgc 12.08%
OM 7.15%
PM (TTM) 5%
GM 18.48%
FCFM N/A
ROA(3y)13.43%
ROA(5y)13.71%
ROE(3y)20.79%
ROE(5y)21.94%
ROIC(3y)17.4%
ROIC(5y)18.17%
ROICexc(3y)17.45%
ROICexc(5y)18.22%
ROICexgc(3y)18.35%
ROICexgc(5y)19.31%
ROCE(3y)24.69%
ROCE(5y)25.84%
ROICexcg growth 3Y-10.65%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y-9.97%
ROICexc growth 5Y1.18%
OM growth 3Y-7.81%
OM growth 5Y3.1%
PM growth 3Y-6.7%
PM growth 5Y4.61%
GM growth 3Y-2.34%
GM growth 5Y2.13%
F-Score3
Asset Turnover1.88
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA 0.91
Cap/Depr 181.92%
Cap/Sales 4.34%
Interest Coverage 250
Cash Conversion 27.68%
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 0.53
Altman-Z 5.11
F-Score3
WACC9.08%
ROIC/WACC1.28
Cap/Depr(3y)104.47%
Cap/Depr(5y)106.99%
Cap/Sales(3y)2.2%
Cap/Sales(5y)2.25%
Profit Quality(3y)96.67%
Profit Quality(5y)102.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.75%
EPS 3Y-0.06%
EPS 5Y8.51%
EPS Q2Q%49.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.4%
Revenue growth 3Y7.51%
Revenue growth 5Y4.01%
Sales Q2Q%-4.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.8%
EBIT growth 3Y-0.88%
EBIT growth 5Y7.24%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-122.41%
FCF growth 3Y-2.64%
FCF growth 5Y1.41%
OCF growth 1Y-72.04%
OCF growth 3Y-0.97%
OCF growth 5Y4.02%